# Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence

> **NCT03396874** · PHASE2 · COMPLETED · sponsor: **University of Michigan** · enrollment: 1435 (actual)

## Conditions studied

- Prostate Cancer
- Prostate Adenocarcinoma
- Prostate Cancer Metastatic
- Prostate Cancer Recurrent

## Interventions

- **DRUG:** 68Ga-PSMA

## Key facts

- **NCT ID:** NCT03396874
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-09
- **Primary completion:** 2022-08-09
- **Final completion:** 2022-08-09
- **Target enrollment:** 1435 (ACTUAL)
- **Last updated:** 2023-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03396874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03396874, "Gallium-68 PSMA-11 PET in Patients With Biochemical Recurrence". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03396874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*